Tollovid™ + Long COVID:

Exploring Viral Persistence in PASC as a Target

Case Studies, Observational, and Retrospective Studies

We're excited to learn how Tollovid is positively impacting those suffering from lingering PASC symptoms.

Long COVID is impacting millions of people. If you have long term effects related to COVID, you’re not alone. Tollovid™ is committed to finding answers. Our research team is working to learn more about the long-term effects of COVID so we can help.

ONGOING MARKET RESEARCH STUDY

We are compiling 35+ individual case studies with PASC participantsas their physicians monitor their symptoms and progress on Tollovid™over 30, 60, and 90 day periods.


UPCOMING CLINICAL STUDIES

We are also conducting a randomized, observer blinded, non-exposurecontrol study to evaluate the safety of Tollovid™ and it’s effects onthe structure/function of the immune system in subjects with Long COVID.We’re currently developing study protocol to evaluate the safety andstructure/function effects of Tollovid.

What is Long COVID?

Building Our Understanding of Recovery:
Long COVID, or post-acute sequelae of COVID-19 (PASC), is acondition marked by the continuation of COVID-19 symptoms—or theemergence of new ones—after recovery from acute COVID-19. It generallyrefers to the persistence of symptoms four weeks or longer after theonset of COVID-19.

About PASC Symptoms:
Long-term effects of COVID can be different for everyone and they canaffect many different parts of the body, such as the heart, brain, andlungs. And people who have PASC, including Long COVID, can havedifferent kinds of effects. These effects may come and go, and they maylast for a few weeks, a few months, or longer.

Observational Study Data: Key Highlights

Case Study Data: April - June 20, 2022 n = 41

1 - In respondents who tried Tollovid during an active infection; 2 - In respondents who tried Tollovid within 9 months of an active infection; 3 - In respondents who tried Tollovid after 9 months of an active infection. Please note that our market studies are still ongoing. Please see MyTollovid.com for the latest information as it becomes available.These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure,or prevent any disease.

100%

of Acute COVID-191 respondents reported
a decrease in Acute COVID Symptoms.

93.7%

of Short Long COVID respondents reported a decrease in Short Long COVID Symptoms.
.

41.6%

of Chronic Long COVID respondents reported
a decrease in Long COVID Symptoms.

83%

of Acute COVID-19 respondents reported that they were happy with their results with Tollovid.

87.5%

of Short Long COVID respondents reported that they were happy with their results with Tollovid.
.

41.6%

of Chronic Long COVID respondents reported that they were happy with their results with Tollovid.

72.7%

of Acute COVID-19 respondents reported a decrease in fatigue.

91.6%

of Short Long COVID respondents reported a decrease in fatigue.
.

50%

of Chronic Long COVID respondents reported a decrease in fatigue.

Observational Case Studies: Key Highlights

CASE STUDY 1

A Patient with Long COVID

“All of her symptoms were eliminated within 1 week. At the end of the week she tested negative by PCR.”

Symptoms Include: Fatigue, Insomnia, Headaches, and Joint Pain

CASE STUDY 2

A Long COVID Patient with Erectile Dysfunction

“After 3 days, his fatigue subsided, his memory improved, the joint pain dissipated, and his erectile dysfunction was resolved.”

Symptoms Include: Fatigue, Insomnia, Brain Fog, Joint Pain, Dizziness, and Erectile Dysfunction

CASE STUDY 3

A Case Study of Paxlovid Rebound Patient

“As of three days ago all her symptoms were resolved. She attributes this recovery to the treatment with Tollovid."

Symptoms Include: Fatigue, Tinnitus, Insomnia, Brain Fog, Fever, Joint Pain, Gastrointestinal Issues, Shortness of Breath, and Changes in Libido

CASE STUDY 4

Day 26 Update from a Long COVID Patient

“After taking Tollovid, my flare-ups are less intense with a rating of only 3 out
of 10. Because of Tollovid, I am suffering less now.”

Symptoms Include: Fatigue, Insomnia, Heart Palpitations, Gastrointestinal Issues, Brain Fog, and Vision Issues

CASE STUDY 5

Day 28 Update from Long COVID with Erectile Dysfunction

“Tollovid has gotten me back to 85% of my pre-COVID state. No other intervention I’ve tried so far has been able to do that.”

Symptoms Include: Fatigue, Joint Pain, Pins & Needles, Headache, Anxiety, Insomnia, Gastrointestinal Issues, Urinary Issues, and Erectile Dysfunction

CASE STUDY 6

Day 45 Update with Long COVID Patient

“After 5 days of restarting Tollovid, I have recovered to 85%. I can run for 30 minutes, and my resting heart rate is back down to 60 bpm.”

Symptoms Include: Fatigue, Headache, Anxiety, Insomnia, Breathing Issues, and Heart Palpitations

CASE STUDY 7

Acute and Long COVID Patient

“She took 12 Tollovid capsules daily for 5 days, and saw her symptoms completely resolve in 3 – 4 days.”

Symptoms Include: Fatigue, Joint Pain, Fever, Clammy Hands, and Vision Issues

How Can You Help?

We are looking for people to volunteer for research studies on Acute COVID and the long-term effects of COVID-19. You can sign up for more information at: